GT Medical Technologies, Inc., a company focused on improving the lives of patients with brain tumors, today announced a publication of prospective, multicenter Phase IV data from the ongoing ...
Real-World Analysis Evaluating Treatment Eligibility and Outcomes in Patients With AML Receiving Intensive Chemotherapy: Insights From an Underrepresented Population Adj PD-1 therapy did not improve ...
New research supports earlier findings that indicate that anesthesia is no more hazardous for the brain at higher doses than at lower doses. General anesthesia makes it possible for millions of ...
From February 2021 to April 2022, patients age 75 years and older under active anticancer treatment were consecutively recruited in six institutions. Remote ePRO feasibility was determined in ...
6don MSN
Adagio Medical (ADGM) Announces Successful Results From US Cardiac Ablation Feasibility Study
Adagio Medical Holdings Inc. (NASDAQ:ADGM) is one of the best up and coming penny stocks to buy. On February 4, Adagio Medical Holdings announced the publication of results from its US Early ...
February 24, 2026—iVascular announced the enrollment of the first patient in the FENCO clinical study evaluating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results